However, as Tregs are heterogeneous with many functionally distinct subsets characterized (144), IL-33-responsive ST2+ Treg subsets may potentially promote APC-mutation-mediated CRC and these should be specifically assessed in future studies (87). The gene discussed is IL33; the disease is colorectal carcinoma.